DDrare
Disease
Drug
Target Gene/Pathway
Contact
JA
Drug
Description in Trials
/
DrugBank
/
KEGG DRUG
Search
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Other
Search results
10
50
100
ALL
descriptions per page:
Showing 1 to 9 of 9 descriptions
Filter by
Reset
|
No.
Drug (Description in trials)
DrugBank
KEGG DRUG
KEGG GENES
KEGG PATHWAY
Disease ID
1
RE-021 (
Sparsentan
)
[1]
Sparsentan
Sparsentan
(
Sparsentan
)
[1]
Sparsentan
Sparsentan
(
Sparsentan
)
💬
1. RE-021 (
Sparsentan
)
×
Name
Other Names
Sparsentan
Sparsentan (USAN/INN)
Filspari (TN)
[2]
AGTR1
AGTR1
,
EDNRA
💬
1. RE-021 (
Sparsentan
)
×
Name
Full Name
AGTR1
angiotensin II receptor type 1
EDNRA
endothelin receptor type A
[17]
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adrenergic signaling in cardiomyocytes
,
Aldosterone synthesis and secretion
,
Apelin signaling pathway
,
Calcium signaling pathway
,
Coronavirus disease - COVID-19
,
Cortisol synthesis and secretion
,
Cushing syndrome
,
Diabetic cardiomyopathy
,
Neuroactive ligand-receptor interaction
,
Pathways in cancer
,
Phospholipase D signaling pathway
,
Renin secretion
,
Renin-angiotensin system
,
Vascular smooth muscle contraction
,
cAMP signaling pathway
,
cGMP-PKG signaling pathway
💬
[17]
AGE-RAGE signaling pathway in diabetic complications
,
Adrenergic signaling in cardiomyocytes
,
A
...
[1]
222
222
💬
1. RE-021 (
Sparsentan
)
×
Disease ID
Name
222
Primary nephrotic syndrome
2
SPARSENTAN
[1]
Sparsentan
Sparsentan
(
Sparsentan
)
[1]
Sparsentan
Sparsentan
(
Sparsentan
)
💬
2.
SPARSENTAN
×
Name
Other Names
Sparsentan
Sparsentan (USAN/INN)
Filspari (TN)
[2]
AGTR1
AGTR1
,
EDNRA
💬
2.
SPARSENTAN
×
Name
Full Name
AGTR1
angiotensin II receptor type 1
EDNRA
endothelin receptor type A
[17]
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adrenergic signaling in cardiomyocytes
,
Aldosterone synthesis and secretion
,
Apelin signaling pathway
,
Calcium signaling pathway
,
Coronavirus disease - COVID-19
,
Cortisol synthesis and secretion
,
Cushing syndrome
,
Diabetic cardiomyopathy
,
Neuroactive ligand-receptor interaction
,
Pathways in cancer
,
Phospholipase D signaling pathway
,
Renin secretion
,
Renin-angiotensin system
,
Vascular smooth muscle contraction
,
cAMP signaling pathway
,
cGMP-PKG signaling pathway
💬
[17]
AGE-RAGE signaling pathway in diabetic complications
,
Adrenergic signaling in cardiomyocytes
,
A
...
[3]
66
66
,
218
,
222
💬
2.
SPARSENTAN
×
Disease ID
Name
66
IgA nephropathy
218
Alport syndrome
222
Primary nephrotic syndrome
3
Sparsentan
compresse
[1]
Sparsentan
Sparsentan
(
Sparsentan
)
[1]
Sparsentan
Sparsentan
(
Sparsentan
)
💬
3.
Sparsentan
compresse
×
Name
Other Names
Sparsentan
Sparsentan (USAN/INN)
Filspari (TN)
[2]
AGTR1
AGTR1
,
EDNRA
💬
3.
Sparsentan
compresse
×
Name
Full Name
AGTR1
angiotensin II receptor type 1
EDNRA
endothelin receptor type A
[17]
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adrenergic signaling in cardiomyocytes
,
Aldosterone synthesis and secretion
,
Apelin signaling pathway
,
Calcium signaling pathway
,
Coronavirus disease - COVID-19
,
Cortisol synthesis and secretion
,
Cushing syndrome
,
Diabetic cardiomyopathy
,
Neuroactive ligand-receptor interaction
,
Pathways in cancer
,
Phospholipase D signaling pathway
,
Renin secretion
,
Renin-angiotensin system
,
Vascular smooth muscle contraction
,
cAMP signaling pathway
,
cGMP-PKG signaling pathway
💬
[17]
AGE-RAGE signaling pathway in diabetic complications
,
Adrenergic signaling in cardiomyocytes
,
A
...
[1]
66
66
💬
3.
Sparsentan
compresse
×
Disease ID
Name
66
IgA nephropathy
4
Sparsentan
tablets/ Over-encapsulated
Sparsentan
tablets
[1]
Sparsentan
Sparsentan
(
Sparsentan
)
[1]
Sparsentan
Sparsentan
(
Sparsentan
)
💬
4.
Sparsentan
tablets/ Over-encapsulated
Sparsentan
tablets
×
Name
Other Names
Sparsentan
Sparsentan (USAN/INN)
Filspari (TN)
[2]
AGTR1
AGTR1
,
EDNRA
💬
4.
Sparsentan
tablets/ Over-encapsulated
Sparsentan
tablets
×
Name
Full Name
AGTR1
angiotensin II receptor type 1
EDNRA
endothelin receptor type A
[17]
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adrenergic signaling in cardiomyocytes
,
Aldosterone synthesis and secretion
,
Apelin signaling pathway
,
Calcium signaling pathway
,
Coronavirus disease - COVID-19
,
Cortisol synthesis and secretion
,
Cushing syndrome
,
Diabetic cardiomyopathy
,
Neuroactive ligand-receptor interaction
,
Pathways in cancer
,
Phospholipase D signaling pathway
,
Renin secretion
,
Renin-angiotensin system
,
Vascular smooth muscle contraction
,
cAMP signaling pathway
,
cGMP-PKG signaling pathway
💬
[17]
AGE-RAGE signaling pathway in diabetic complications
,
Adrenergic signaling in cardiomyocytes
,
A
...
[1]
66
66
💬
4.
Sparsentan
tablets/ Over-encapsulated
Sparsentan
tablets
×
Disease ID
Name
66
IgA nephropathy
5
Sparsentan
tablets/Over-encapsulated
Sparsentan
tablets
[1]
Sparsentan
Sparsentan
(
Sparsentan
)
[1]
Sparsentan
Sparsentan
(
Sparsentan
)
💬
5.
Sparsentan
tablets/Over-encapsulated
Sparsentan
tablets
×
Name
Other Names
Sparsentan
Sparsentan (USAN/INN)
Filspari (TN)
[2]
AGTR1
AGTR1
,
EDNRA
💬
5.
Sparsentan
tablets/Over-encapsulated
Sparsentan
tablets
×
Name
Full Name
AGTR1
angiotensin II receptor type 1
EDNRA
endothelin receptor type A
[17]
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adrenergic signaling in cardiomyocytes
,
Aldosterone synthesis and secretion
,
Apelin signaling pathway
,
Calcium signaling pathway
,
Coronavirus disease - COVID-19
,
Cortisol synthesis and secretion
,
Cushing syndrome
,
Diabetic cardiomyopathy
,
Neuroactive ligand-receptor interaction
,
Pathways in cancer
,
Phospholipase D signaling pathway
,
Renin secretion
,
Renin-angiotensin system
,
Vascular smooth muscle contraction
,
cAMP signaling pathway
,
cGMP-PKG signaling pathway
💬
[17]
AGE-RAGE signaling pathway in diabetic complications
,
Adrenergic signaling in cardiomyocytes
,
A
...
[1]
66
66
💬
5.
Sparsentan
tablets/Over-encapsulated
Sparsentan
tablets
×
Disease ID
Name
66
IgA nephropathy
6
Sparsentan
tablets/over-encapsulated Spasenten tablets
[1]
Sparsentan
Sparsentan
(
Sparsentan
)
[1]
Sparsentan
Sparsentan
(
Sparsentan
)
💬
6.
Sparsentan
tablets/over-encapsulated Spasenten tablets
×
Name
Other Names
Sparsentan
Sparsentan (USAN/INN)
Filspari (TN)
[2]
AGTR1
AGTR1
,
EDNRA
💬
6.
Sparsentan
tablets/over-encapsulated Spasenten tablets
×
Name
Full Name
AGTR1
angiotensin II receptor type 1
EDNRA
endothelin receptor type A
[17]
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adrenergic signaling in cardiomyocytes
,
Aldosterone synthesis and secretion
,
Apelin signaling pathway
,
Calcium signaling pathway
,
Coronavirus disease - COVID-19
,
Cortisol synthesis and secretion
,
Cushing syndrome
,
Diabetic cardiomyopathy
,
Neuroactive ligand-receptor interaction
,
Pathways in cancer
,
Phospholipase D signaling pathway
,
Renin secretion
,
Renin-angiotensin system
,
Vascular smooth muscle contraction
,
cAMP signaling pathway
,
cGMP-PKG signaling pathway
💬
[17]
AGE-RAGE signaling pathway in diabetic complications
,
Adrenergic signaling in cardiomyocytes
,
A
...
[1]
66
66
💬
6.
Sparsentan
tablets/over-encapsulated Spasenten tablets
×
Disease ID
Name
66
IgA nephropathy
7
Sparsentan
tablets/Overencapsulated
Sparsentan
tablets
[1]
Sparsentan
Sparsentan
(
Sparsentan
)
[1]
Sparsentan
Sparsentan
(
Sparsentan
)
💬
7.
Sparsentan
tablets/Overencapsulated
Sparsentan
tablets
×
Name
Other Names
Sparsentan
Sparsentan (USAN/INN)
Filspari (TN)
[2]
AGTR1
AGTR1
,
EDNRA
💬
7.
Sparsentan
tablets/Overencapsulated
Sparsentan
tablets
×
Name
Full Name
AGTR1
angiotensin II receptor type 1
EDNRA
endothelin receptor type A
[17]
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adrenergic signaling in cardiomyocytes
,
Aldosterone synthesis and secretion
,
Apelin signaling pathway
,
Calcium signaling pathway
,
Coronavirus disease - COVID-19
,
Cortisol synthesis and secretion
,
Cushing syndrome
,
Diabetic cardiomyopathy
,
Neuroactive ligand-receptor interaction
,
Pathways in cancer
,
Phospholipase D signaling pathway
,
Renin secretion
,
Renin-angiotensin system
,
Vascular smooth muscle contraction
,
cAMP signaling pathway
,
cGMP-PKG signaling pathway
💬
[17]
AGE-RAGE signaling pathway in diabetic complications
,
Adrenergic signaling in cardiomyocytes
,
A
...
[1]
66
66
💬
7.
Sparsentan
tablets/Overencapsulated
Sparsentan
tablets
×
Disease ID
Name
66
IgA nephropathy
8
Sparsentan
/Over-encapsulated
Sparsentan
tablet
[1]
Sparsentan
Sparsentan
(
Sparsentan
)
[1]
Sparsentan
Sparsentan
(
Sparsentan
)
💬
8.
Sparsentan
/Over-encapsulated
Sparsentan
tablet
×
Name
Other Names
Sparsentan
Sparsentan (USAN/INN)
Filspari (TN)
[2]
AGTR1
AGTR1
,
EDNRA
💬
8.
Sparsentan
/Over-encapsulated
Sparsentan
tablet
×
Name
Full Name
AGTR1
angiotensin II receptor type 1
EDNRA
endothelin receptor type A
[17]
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adrenergic signaling in cardiomyocytes
,
Aldosterone synthesis and secretion
,
Apelin signaling pathway
,
Calcium signaling pathway
,
Coronavirus disease - COVID-19
,
Cortisol synthesis and secretion
,
Cushing syndrome
,
Diabetic cardiomyopathy
,
Neuroactive ligand-receptor interaction
,
Pathways in cancer
,
Phospholipase D signaling pathway
,
Renin secretion
,
Renin-angiotensin system
,
Vascular smooth muscle contraction
,
cAMP signaling pathway
,
cGMP-PKG signaling pathway
💬
[17]
AGE-RAGE signaling pathway in diabetic complications
,
Adrenergic signaling in cardiomyocytes
,
A
...
[1]
222
222
💬
8.
Sparsentan
/Over-encapsulated
Sparsentan
tablet
×
Disease ID
Name
222
Primary nephrotic syndrome
9
Sparsentan
/Over-encapsulated
Sparsentan
tablets
[1]
Sparsentan
Sparsentan
(
Sparsentan
)
[1]
Sparsentan
Sparsentan
(
Sparsentan
)
💬
9.
Sparsentan
/Over-encapsulated
Sparsentan
tablets
×
Name
Other Names
Sparsentan
Sparsentan (USAN/INN)
Filspari (TN)
[2]
AGTR1
AGTR1
,
EDNRA
💬
9.
Sparsentan
/Over-encapsulated
Sparsentan
tablets
×
Name
Full Name
AGTR1
angiotensin II receptor type 1
EDNRA
endothelin receptor type A
[17]
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
Adrenergic signaling in cardiomyocytes
,
Aldosterone synthesis and secretion
,
Apelin signaling pathway
,
Calcium signaling pathway
,
Coronavirus disease - COVID-19
,
Cortisol synthesis and secretion
,
Cushing syndrome
,
Diabetic cardiomyopathy
,
Neuroactive ligand-receptor interaction
,
Pathways in cancer
,
Phospholipase D signaling pathway
,
Renin secretion
,
Renin-angiotensin system
,
Vascular smooth muscle contraction
,
cAMP signaling pathway
,
cGMP-PKG signaling pathway
💬
[17]
AGE-RAGE signaling pathway in diabetic complications
,
Adrenergic signaling in cardiomyocytes
,
A
...
[1]
222
222
💬
9.
Sparsentan
/Over-encapsulated
Sparsentan
tablets
×
Disease ID
Name
222
Primary nephrotic syndrome